Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for NHNKY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NHNKY and 80,000+ other tickers.
See exactly how NHNKY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NHNKY and 80,000+ other tickers.
Nihon Kohden Corporation specializes in the comprehensive lifecycle of medical electronic equipment, from research and development and manufacturing to sales, repair, and ongoing maintenance. The company operates across a global footprint encompassing Japan, the Americas, Europe, and the wider Asian market, as well as other international regions. Their diverse product portfolio includes advanced physiological measurement devices such as electroencephalographs (EEGs), electrocardiographs (ECGs), evoked potential and electromyogram instruments, and polygraphs tailored for catheterization…
IRVINE, Calif.--(BUSINESS WIRE)-- #ExecutiveLeadership--Nihon Kohden, a leading provider of patient monitoring, neurology, ventilation and digital health solutions, today announced an expanded executive leadership structure designed to increase organizational capacity and strengthen alignment across the customer experience. Effective August 3, Zac Ballard was promoted to executive vice president, commercial operations, taking on leadership of sales and marketing across all four of the company's business units — Patien.
IRVINE, Calif.--(BUSINESS WIRE)-- #CriticalCare--Nihon Kohden America today announced three advanced capabilities now available on the NKV-550 Series Ventilator System. Non-invasive Muscle Pressure (Pmus) monitoring gives clinicians a continuous, real-time measurement of how hard a patient is working to breathe, without invasive interventions. Adaptive Ventilation Mode (AVM) continuously calculates and adjusts ventilator settings based on the patient's real-time lung mechanics, reducing the manual bedside adju.
Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) and Nuwellis (NASDAQ: NUWE - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Valuation and Earnings This table compares Nihon Kohden
Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) shares gapped up before the market opened on Friday. The stock had previously closed at $10.55, but opened at $11.2699. Nihon Kohden shares last traded at $11.2699, with a volume of 250 shares trading hands. Nihon Kohden Stock Performance The stock has a market capitalization of
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader in neurodiagnostic technology, will showcase its integrated EEG portfolio at the American Epilepsy Society (AES) 2025 Annual Meeting, held December 5–9 in Atlanta. Attendees are invited to Booth #725 to explore solutions shaped through extensive collaboration with the clinicians who use them—bringing together mobility, connectivity and performance to advance neurological care. With a history of advancing EEG technology that predates.